Cover Image
市場調查報告書

切除技術的全球市場:產品 (高頻,超音波,不可逆電穿孔,冷凍治療,微波) ·各用途 (心臟血管,癌症,疼痛處理,美容整形,眼科,婦產科) 的預測 ∼2020年

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020

出版商 MarketsandMarkets 商品編碼 247577
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
切除技術的全球市場:產品 (高頻,超音波,不可逆電穿孔,冷凍治療,微波) ·各用途 (心臟血管,癌症,疼痛處理,美容整形,眼科,婦產科) 的預測 ∼2020年 Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020
出版日期: 2016年02月08日 內容資訊: 英文 169 Pages
簡介

全球切除技術市場預測在2015年以後將以年複合成長率 (CAGR) 10.5%成長,到2020年達到44億4,000萬美元的規模。2015年,美國,德國,法國及英國等成熟市場佔相當大佔有率,但在今後5年一般認為亞太地區的年複合成長率將是最高。癌症罹患率的上升,心臟血管疾病盛行率的擴大,下一代切除產品及技術的登場,微創治療的引進擴大,醫院,外科手術及切除中心數的增加,以及醫療成本補償方案的改善等,是促進市場發展的主要原因。

本報告網羅全球切除技術市場,概括市場概要,市場發展促進·阻礙因素,市場上課題及機會,再彙整各類型·各產品·各用途·各地區市場現況與展望相關調查分析,競爭環境,主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 高級見解

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 市場發展推動因素
      • 切除治療數的增加
      • 癌症罹患率的上升
      • 心臟血管疾病盛行率的擴大
      • 下一代切除產品及技術的登場
      • 微創治療的引進擴大
      • 醫院,外科手術及切除中心數的增加
      • 確立的市場上補償方案的改善
    • 市場發展阻礙因素
      • 開發中國家的設備的再利用及再加工
      • 醫療成本控制對策
    • 課題
      • 嚴格法規指南
      • 治療的課題
    • 市場機會
      • 針對新切除設備開發的資金增加
      • 新興市場
      • 訓練計劃數的增加
    • 趨勢
      • 市場重組
      • 越發以開發中國家為重點的國際企業

第6章 全球切除技術市場,各類型

  • 簡介
  • 射頻消融術
  • 雷射/光切除
  • 超音波切除
  • 電力的切除
  • 冷凍切除
  • 微切除
  • 不可逆電穿孔
  • 熱水切除

第7章 全球切除技術市場,各產品

  • 簡介
  • 高頻ABLATORS
  • 雷射/光ABLATORS
  • 超音波ABLATORS
  • 電力的ABLATORS
  • 冷凍ABLATORS
  • maikuroABLATORS
  • 不可逆電穿孔
  • 熱水ABLATORS

第8章 全球切除技術市場,各用途

  • 簡介
  • 心臟血管疾病治療
  • 癌症治療
    • 肝癌
    • 腎臟癌
    • 前列腺癌
    • 肺癌
    • 骨轉移
    • 乳癌
  • 眼科治療
  • 疼痛處理
  • 婦產科治療
  • 泌尿系統治療
  • 整形外科治療
  • 美容整形/美容整形手術
  • 其他治療

第9章 全球切除技術市場,各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他亞太地區
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
    • 切除技術市場上主要企業
  • 競爭情形·趨勢
    • 新產品發表·認證
    • 合併·收購
    • 地區擴大
    • 協定,合資企業
    • 其他趨勢

第11章 企業簡介 (業績,產品與服務,主要策略,最近的動向)

  • 簡介
  • MEDTRONIC PLC
  • BIOSENSE WEBSTER, INC. (JOHNSON & JOHNSON INC.的子公司)
  • ST. JUDE MEDICAL, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • ANGIODYNAMICS, INC.
  • ATRICURE, INC.
  • CONMED CORPORATION
  • OLYMPUS CORPORATION
  • SMITH & NEPHEW
  • GALIL MEDICAL INC.

第12章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 2738

The global ablation technologies market is estimated to grow at a CAGR of 10.5% from 2015 to 2020 and will be valued at USD 4.44 billion. Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the ablation technologies market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as growing popularity of minimally invasive surgeries, government efforts to increase population access for elective surgeries, rising focus of global players, large population base and improving healthcare infrastructure and the rising focus of international and domestic players on the Asia-Pacific ablation technologies market are propelling its growth.

The growth of the ablation technologies market is driven by factors such as increasing number of ablation procedures, rising incidence of cancer, growing prevalence of cardiovascular diseases, emergence of next-generation ablation products and technologies, growing adoption of minimally-invasive procedures, increasing number of hospitals, surgical, and ablation centers and improving reimbursement scenario in established markets. However, factors such as reuse and reprocessing of devices in developing countries, Healthcare cost-containment measures, and ongoing healthcare reforms in the U.S. are restraining the growth of the market. Increasing funding for the development of novel ablation devices, emerging markets such as China, India, and Mexico are creating opportunities for the players involved in the ablation technologies market.

In this report, the global ablation technologies market has been segmented on the basis of type of product (light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators), type of technology (light/laser, radiofrequency, electrical, ultrasound, microwave, cryoblation, and hydrothermal technologies), and type of application (cancer, cardiovascular, gynecological, ophthalmological, urological, orthopedic, pain management and cosmetic surgery). The radiofrequency ablators market is estimated to account for the largest share of the global ablation technologies market in 2015, followed by the light/laser ablators market. Use of RF ablators in primary interventional therapy for the treatment of many cardiac arrhythmias is a key factor driving the segment. Better temperature control by RF ablators as compared to other ablation products (such as electrical and microwave ablators), clinical advantages offered by temperature-controlled RF ablators over traditional ablation approaches are further supporting the growth of the segment.

The microwave ablators segment is estimated to grow at the highest CAGR from 2015 to 2020. This high growth is primarily due to its high success rate in cancer treatment as well as advantages offered by microwave ablation over RF ablation (for example, microwave ablation devices can produce larger ablation zones and do not suffer as much from the heat sink effect that can handicap RF ablation).

Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global ablation technologies market in 2015, followed by Europe. The ablation technologies market in North America is primarily driven by various factors including presence of a large number of ablation product manufacturers, significant rate of adoption of ablation treatment, large patient population base, growing demand for minimally invasive surgical procedures and continuously rising prevalence of chronic disorders such as cancer and heart diseases (especially atrial fibrillation).

The global ablation technologies market is highly competitive, with a large number of global and local players. As of 2014, the global ablation technologies market was dominated by Medtronic, Inc. (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.), which together accounted for ~50% of the market. New product launches, pipeline product enhancements, and partnerships, agreements, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the ablation technologies market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis -industry analysis (industry trends, PEST analysis, and Porter's five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the ablation technologies market, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on ablation devices offered by the top 10 players in the ablation technologies market. The report analyzes the ablation technologies market by type of product, technology, and application across geographies
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the ablation technologies market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various ablation devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ablation technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the ablation technologies market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. MARKETS COVERED
    • 1.4.1. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
    • 2.2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.4. RESEARCH METHODOLOGY: TOP-DOWN APPROACH
    • 2.2.5. RESEARCH METHODOLOGY: BOTTOM-UP APPROACH
  • 2.3. RESEARCH DESIGN
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.4.1. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT MARKET SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL ABLATION TECHNOLOGIES MARKET OVERVIEW (2015-2020)
  • 4.2. GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ABLATION TECHNOLOGIES MARKET
  • 4.3. GLOBAL ABLATION TECHNOLOGIES MARKET, BY TYPE AND REGION (2015)
  • 4.4. GLOBAL ABLATION TECHNOLOGIES MARKET, BY APPLICATION AND REGION (2015 VS. 2020)
  • 4.5. GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY PRODUCT (2015 VS. 2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing number of ablation procedures
      • 5.3.1.2. Rising incidence of cancer
      • 5.3.1.3. Growing prevalence of cardiovascular diseases
      • 5.3.1.4. Emergence of next-generation ablation products and technologies
      • 5.3.1.5. Growing adoption of minimally invasive procedures
      • 5.3.1.6. Increasing number of hospitals, surgical, and ablation centers
      • 5.3.1.7. Improving reimbursement scenario in established markets
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Reuse and reprocessing of devices in developing countries
      • 5.3.2.2. Healthcare cost-containment measures
    • 5.3.3. CHALLENGES
      • 5.3.3.1. Stringent regulatory guidelines
      • 5.3.3.2. Therapeutic challenges
    • 5.3.4. OPPORTUNITIES
      • 5.3.4.1. Increasing funding for the development of novel ablation devices
      • 5.3.4.2. Emerging markets
      • 5.3.4.3. Rising number of training programs
    • 5.3.5. TRENDS
      • 5.3.5.1. Market consolidation
      • 5.3.5.2. Increasing focus of global players towards developing nations

6. GLOBAL ABLATION TECHNOLOGIES MARKET, BY TYPE 49

  • 6.1. INTRODUCTION
  • 6.2. RADIOFREQUENCY ABLATION
  • 6.3. LASER/LIGHT ABLATION
  • 6.4. ULTRASOUND ABLATION
  • 6.5. ELECTRICAL ABLATION
  • 6.6. CRYOABLATION
  • 6.7. MICROWAVE ABLATION
  • 6.8. HYDROTHERMAL ABLATION

7. GLOBAL ABLATION TECHNOLOGIES MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. RADIOFREQUENCY ABLATORS
    • 7.2.1. TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
    • 7.2.2. FLUID-COOLED RADIOFREQUENCY ABLATORS
    • 7.2.3. ROBOTIC CATHETER MANIPULATION SYSTEMS
  • 7.3. LASER/LIGHT ABLATORS
    • 7.3.1. EXCIMER LASER ABLATORS
    • 7.3.2. COLD LASER ABLATORS
  • 7.4. ULTRASOUND ABLATORS
    • 7.4.1. ULTRASONIC SURGICAL ABLATION SYSTEMS
    • 7.4.2. HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS
    • 7.4.3. EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS
    • 7.4.4. MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (MRGFUS) ABLATORS
  • 7.5. ELECTRICAL ABLATORS
    • 7.5.1. ARGON PLASMA/BEAM COAGULATORS
    • 7.5.2. IRREVERSIBLE ELECTROPORATION ABLATORS
  • 7.6. CRYOABLATION DEVICES
    • 7.6.1. TISSUE CONTACT PROBES
    • 7.6.2. TISSUE SPRAY PROBES
    • 7.6.3. EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
  • 7.7. MICROWAVE ABLATORS
    • 7.7.1. MICROWAVE THERMOTHERAPY DEVICES
  • 7.8. HYDROTHERMAL ABLATORS
    • 7.8.1. ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES

8. GLOBAL ABLATION TECHNOLOGIES MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CARDIOVASCULAR DISEASE TREATMENT
  • 8.3. CANCER TREATMENT
    • 8.3.1. LIVER CANCER
    • 8.3.2. KIDNEY CANCER
    • 8.3.3. PROSTATE CANCER
    • 8.3.4. LUNG CANCER
    • 8.3.5. BONE METASTASIS
    • 8.3.6. BREAST CANCER
  • 8.4. OPHTHALMOLOGIC TREATMENT
  • 8.5. PAIN MANAGEMENT
  • 8.6. GYNECOLOGICAL TREATMENT
  • 8.7. UROLOGICAL TREATMENT
  • 8.8. ORTHOPEDIC TREATMENT
  • 8.9. COSMETIC/ AESTHETIC SURGERY
  • 8.10. OTHER TREATMENTS

9. GLOBAL ABLATION TECHNOLOGIES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. KEY PLAYERS IN THE ABLATION TECHNOLOGIES MARKET
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. NEW PRODUCT LAUNCHES & APPROVALS
    • 10.3.2. MERGERS & ACQUISITIONS
    • 10.3.3. GEOGRAPHICAL EXPANSIONS
    • 10.3.4. AGREEMENTS AND JOINT VENTURES
    • 10.3.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES*

  • 11.1. INTRODUCTION
  • 11.2. MEDTRONIC PLC
  • 11.3. BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON INC.)
  • 11.4. ST. JUDE MEDICAL, INC.
  • 11.5. BOSTON SCIENTIFIC CORPORATION
  • 11.6. ANGIODYNAMICS, INC.
  • 11.7. ATRICURE, INC.
  • 11.8. CONMED CORPORATION
  • 11.9. OLYMPUS CORPORATION
  • 11.10. SMITH & NEPHEW
  • 11.11. GALIL MEDICAL INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 2: ABLATION TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 3: RADIOFREQUENCY ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 4: LASER/LIGHT ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 5: ULTRASOUND ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: ELECTRICAL ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: CRYOABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: MICROWAVE ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: HYDROTHERMAL ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 11: RADIOFREQUENCY ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 12: RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: LASER/LIGHT ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 17: LASER/LIGHT ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: EXCIMER LASER ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: COLD LASER ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: ULTRASOUND ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 21: ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: ELECTRICAL ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 27: ELECTRICAL ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: ARGON PLASMA/BEAM COAGULATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: IRREVERSIBLE ELECTROPORATION ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: CRYOABLATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 31: CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: TISSUE CONTACT PROBES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: TISSUE SPRAY PROBES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: MICROWAVE ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: HYDROTHERMAL ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 38: ABLATION TECHNOLOGIES MARKET SIZE FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: ABLATION TECHNOLOGIES MARKET SIZE FOR CANCER TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: ABLATION TECHNOLOGIES MARKET SIZE FOR OPHTHALMOLOGIC TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: ABLATION TECHNOLOGIES MARKET SIZE FOR PAIN MANAGEMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: ABLATION TECHNOLOGIES MARKET SIZE FOR GYNECOLOGICAL TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: ABLATION TECHNOLOGIES MARKET SIZE FOR UROLOGIC TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 44: ABLATION TECHNOLOGIES MARKET SIZE FOR ORTHOPEDIC TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 45: ABLATION TECHNOLOGIES MARKET SIZE FOR COSMETIC/ AESTHETIC SURGERY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 46: ABLATION TECHNOLOGIES MARKET SIZE FOR OTHER TREATMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 47: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 48: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 49: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 50: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 51: U.S.: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: CANADA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 56: GERMANY: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: FRANCE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: U.K.: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: REST OF EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 20130U2020 (USD MILLION)
  • TABLE 63: JAPAN: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: CHINA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: INDIA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: APAC: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 69: TOP 5 NEW PRODUCT LAUNCHES & APPROVALS, 2012-2015
  • TABLE 70: MERGERS & ACQUISITIONS, 2012-2015
  • TABLE 71: GEOGRAPHICAL EXPANSIONS, 2012-2015
  • TABLE 72: TOP 3 AGREEMENTS AND JOINT VENTURES, 2012-2015
  • TABLE 73: TOP 5 OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL ABLATION TECHNOLOGIES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 5: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE (2015 VS. 2020)
  • FIGURE 6: ABLATION TECHNOLOGIES MARKET SHARE, BY PRODUCT (2015 VS. 2020)
  • FIGURE 7: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION (2015 VS. 2020)
  • FIGURE 8: ABLATION TECHNOLOGIES MARKET SHARE, BY REGION (2015)
  • FIGURE 9: RISING INCIDENCES OF CANCER & CARDIAC DISEASES-PRIMARY DRIVER OF THE ABLATION TECHNOLOGIES MARKET
  • FIGURE 10: INDIA AND CHINA ARE THE MOST LUCRATIVE MARKETS FOR ABLATION PRODUCT MANUFACTURERS
  • FIGURE 11: U.S. TO COMMAND THE LARGEST SHARE OF THE ABLATION TECHNOLOGIES MARKET IN 2015
  • FIGURE 12: CARDIOVASCULAR DISEASE TREATMENT SEGMENT TO DOMINATE THE ABLATION TECHNOLOGIES MARKET IN 2020
  • FIGURE 13: RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE MARKET TILL 2020
  • FIGURE 14: ABLATION TECHNOLOGIES MARKET SEGMENTATION
  • FIGURE 15: GLOBAL ABLATION TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: GLOBAL PREVALENCE OF CANCER: EXPECTED TREND TILL 2020
  • FIGURE 17: INCREASING NUMBER OF ABLATION PROCEDURES PROPELLING THE MARKET GROWTH
  • FIGURE 18: COST-CONTAINMENT MEASURES BY GOVERNMENTS ARE RESTRAINING THE MARKET GROWTH FOR ABLATION DEVICES
  • FIGURE 19: STRINGENT REGULATORY GUIDELINES RESTRAIN THE GROWTH OF THE ABLATION TECHNOLOGIES MARKET
  • FIGURE 20: DEVELOPING COUNTRIES PAVE NEWER GROWTH AVENUES FOR MARKET PLAYERS
  • FIGURE 21: MICROWAVE ABLATION IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL ABLATION TECHNOLOGIES MARKET
  • FIGURE 22: MICROWAVE ABLATION IS THE FASTEST-GROWING SEGMENT IN THE GLOBAL ABLATION TECHNOLOGIES MARKET
  • FIGURE 23: CARDIOVASCULAR DISEASE TREATMENT ABLATION MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 24: GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY COUNTRY (2015-2020)
  • FIGURE 25: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 26: EUROPE: ABLATION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 27: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 28: LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES & APPROVALS AS THEIR KEY GROWTH STRATEGY FROM 2012 TO 2015
  • FIGURE 29: GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 30: NEW PRODUCT LAUNCHES & APPROVALS WAS THE KEY STRATEGY
  • FIGURE 31: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 32: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 33: JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • FIGURE 34: ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 35: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 36: ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
  • FIGURE 37: ATRICURE, INC.: COMPANY SNAPSHOT
  • FIGURE 38: CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 39: OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 40: SMITH & NEPHEW: COMPANY SNAPSHOT
Back to Top